A

SEC EDGAR - Form 4 insider activity

Alnylam Pharmaceuticals, Inc. $ALNY

Tracked equity - 1 filings indexed by Nortis

Nortis signal thesis

Selling activity is leading recent insider flow. Review size, role and filing context.

0

OM buys - 90d

1

OM sells - 90d

0

Routine filings

0

Cluster filings

$398.9K

Largest trade

41/100

Avg signal score

Filing tape

Recent filings

Last 30d: 1
Open-market SellNotable 41/100
filed 2026-10-06
SBInsider

SUPRAN BRYAN - EVP, CLO and Secretary - $398.9K

Insiders sell for many reasons (diversification, tax, personal); size and clustering matter more than a single sale.

View source filing